Association of genetic polymorphisms of interleukins with new-onset diabetes after transplantation in renal transplantation

Transplantation

Volumn 93, Issue 9, 2012, Pages 900-907

  Kim, Yang Gyun ^a   Ihm, Chun Gyoo ^a   Lee, Tae Won ^a   Lee, Sang Ho ^a   Jeong, Kyung Hwan ^a   Moon, Ju Young ^a   Chung, Joo Ho ^a   Kim, Su Kang ^a   Kim, Yeong Hoon ^b  

^a Kyung Hee University Hospital   (South Korea)

^b Inje University College of Medicine   (South Korea)

Author keywords

Interleukin; Kidney transplantation; NODAT; Single nucleotide polymorphism

Indexed keywords

CREATININE; CYTOKINE; GLUCOSE; HEMOGLOBIN A1C; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 7 RECEPTOR ALPHA; PREDNISOLONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; HEPATITIS C; HUMAN; INCIDENCE; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RECIPIENT; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT DURATION;

ADULT; BODY MASS INDEX; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENOTYPE; HUMANS; INSULIN-SECRETING CELLS; INTERLEUKINS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84862832585     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182497534     Document Type: Article

References (53)

1. Ducloux D, Kazory A, Chalopin JM. Posttransplant diabetes mellitus and atherosclerotic events in renal transplant recipients: A prospective study. Transplantation 2005; 79: 438.
2. Warnock DG. Polymorphism in the beta subunit and Na+ transport. J Am Soc Nephrol 1996; 7: 2490.
3. Schnitzler M. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 1318; author reply 1319.
4. Davidson JA, Wilkinson A. New-onset diabetes after transplantation 2003 International Consensus Guidelines: An endocrinologist's view. Diabetes Care 2004; 27: 805.
5. Bodziak KA, Hricik DE. New-onset diabetes mellitus after solid organ transplantation. Transpl Int 2009; 22: 519.
6. Nam JH, Mun JI, Kim SI, et al. Beta-cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus. Transplantation 2001; 71: 1417.
7. Hur KY, Kim MS, Kim YS, et al. Risk factors associated with the onset and progression of posttransplantation diabetes in renal allograft recipients. Diabetes Care 2007; 30: 609.
8. Biarnes M, Montolio M, Nacher V, et al. Beta-cell death and mass in syngeneically transplanted islets exposed to short-and long-term hyperglycemia. Diabetes 2002; 51: 66.
9. Butler AE, Janson J, Bonner-Weir S, et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52: 102.
10. Mandrup-Poulsen T. The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 1996; 39: 1005.
11. Larsen CM, Faulenbach M, Vaag A, et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007; 356: 1517.
12. Seckinger P, Lowenthal JW, Williamson K, et al. A urine inhibitor of interleukin 1 activity that blocks ligand binding. J Immunol 1987; 139: 1546.
13. Dayer-Metroz MD, Wollheim CB, Seckinger P, et al. A natural interleukin 1 (IL-1) inhibitor counteracts the inhibitory effect of IL-1 on insulin production in cultured rat pancreatic islets. J Autoimmun 1989; 2: 163.
14. Volarevic V, Al-Qahtani A, Arsenijevic N, et al. Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis. Autoimmunity 2010; 43: 255.
15. Berman MA, Sandborg CI, Wang Z, et al. Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus. J Immunol 1996; 157: 4690.
16. Bradley LM, Asensio VC, Schioetz LK, et al. Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes. J Immunol 1999; 162: 2511.
17. Luotola K, Paakkonen R, Alanne M, et al. Association of variation in the interleukin-1 gene family with diabetes and glucose homeostasis. J Clin Endocrinol Metab 2009; 94: 4575.
18. Nunez C, Santiago JL, Varade J, et al. IL4 in the 5q31 context: Association studies of type 1 diabetes and rheumatoid arthritis in the Spanish population. Immunogenetics 2008; 60: 19.
19. Oh IH, Oh C, Kim HJ, et al. Genetic associations of IL1RN polymorphisms with metabolic syndrome in a Korean population. Exp Clin Endocrinol Diabetes 2010; 118: 333.
20. Santiago JL, Alizadeh BZ, Martinez A, et al. Study of the association between the CAPSL-IL7R locus and type 1 diabetes. Diabetologia 2008; 51: 1653.
21. Emamaullee JA, Davis J, Merani S, et al. Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 2009; 58: 1302.
22. Todd JA, Walker NM, Cooper JD, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007; 39: 857.
23. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225.
24. Numakura K, Satoh S, Tsuchiya N, et al. Incidence and risk factors of clinical characteristics, tacrolimus pharmacokinetics, and related genomic polymorphisms for posttransplant diabetes mellitus in the early stage of renal transplant recipients. Transplant Proc 2005; 37: 1865.
25. Kang ES, Kim MS, Kim YS, et al. A variant of the transcription factor 7-like 2 (TCF7L2) gene and the risk of posttransplantation diabetes mellitus in renal allograft recipients. Diabetes Care 2008; 31: 63.
26. Kang ES, Kim MS, Kim YS, et al. A polymorphism in the zinc transporter gene SLC30A8 confers resistance against posttransplantation diabetes mellitus in renal allograft recipients. Diabetes 2008; 57: 1043.
27. Jeong KH, Moon JY, Chung JH, et al. Significant associations between CCL5 gene polymorphisms and post-transplantational diabetes mellitus in Korean renal allograft recipients. Am J Nephrol 2010; 32: 356.
28. Hjelmesaeth J, Hagen M, Hartmann A, et al. The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantation. Clin Transplant 2002; 16: 389.
29. Luotola K, Pietilä A, Zeller T, et al. Associations between interleukin-1 (IL-1) gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetes. J Intern Med 2011; 269: 322.
30. Herder C, Brunner EJ, Rathmann W, et al. Elevated levels of the antiinflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: The Whitehall II study. Diabetes Care 2009; 32: 421.
31. Marculescu R, Endler G, Schillinger M, et al. Interleukin-1 receptor antagonist genotype is associated with coronary atherosclerosis in patients with type 2 diabetes. Diabetes 2002; 51: 3582.
32. Rafiq S, Melzer D, Weedon MN, et al. Gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetes. Diabetologia 2008; 51: 2205.
33. Smyth DJ, Howson JM, Payne F, et al. Analysis of polymorphisms in 16 genes in type 1 diabetes that have been associated with other immune-mediated diseases. BMC Med Genet 2006; 7: 20.
34. Rapoport MJ, Bistritzer T, Aharoni D, et al. TH1/TH2 cytokine secretion of first degree relatives of T1DM patients. Cytokine 2005; 30: 219.
35. Plagnol V, Howson JM, Smyth DJ, et al. Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. PLoS Genet 2011; 7: e1002216.
36. Espino-Paisan L, De La Calle H, Fernandez-Arquero M, et al. Study of polymorphisms in 4q27, 10p15, and 22q13 regions in autoantibodies stratified type 1 diabetes patients. Autoimmunity 2011; 44: 624.
37. Barrett JC, Clayton DG, Concannon P, et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009; 41: 703.
38. Huang HY, Thuita L, Strickland P, et al. Frequencies of single nucleotide polymorphisms in genes regulating inflammatory responses in a community-based population. BMC Genet 2007; 8: 7.
39. Maier LM, Chapman J, Howson JM, et al. No evidence of association or interaction between the IL4RA, IL4, and IL13 genes in type 1 diabetes. Am J Hum Genet 2005; 76: 517.
40. Scarpelli D, Cardellini M, Andreozzi F, et al. Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in Caucasian Italian subjects. Diabetes 2006; 55: 1529.
41. Chang YH, Huang CN, Wu CY, et al. Association of interleukin-10 A-592C and T-819C polymorphisms with type 2 diabetes mellitus. Hum Immunol 2005; 66: 1258.
42. Reynier F, Cazalis MA, Lecoq A, et al. Lack of association of IL-10 promoter gene variants with type 1 diabetes in a French population. Hum Immunol 2006; 67: 311.
43. Lu MY, Lakkakula BV, Liao YC, et al. Lack of association between the IL-10 gene polymorphisms and features of the metabolic syndrome. J Investig Med 2011; 59: 267.
44. Bettelli E, Korn T, Kuchroo VK. Th17: The third member of the effector T cell trilogy. Curr Opin Immunol 2007; 19: 652.
45. Korn T, Oukka M, Kuchroo V, et al. Th17 cells: Effector T cells with inflammatory properties. Semin Immunol 2007; 19: 362.
46. Ely LK, Fischer S, Garcia KC. Structural basis of receptor sharing by interleukin 17 cytokines. Nat Immunol 2009; 10: 1245.
47. Yang XO, Nurieva R, Martinez GJ, et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008; 29: 44.
48. Tzartos JS, Friese MA, Craner MJ, et al. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol 2008; 172: 146.
49. Wong CK, Ho CY, Li EK, et al. Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 2000; 9: 589.
50. Mills KH. Induction, function and regulation of IL-17-producing T cells. Eur J Immunol 2008; 38: 2636.
51. Bayer AL, Lee JY, de la Barrera A, et al. A function for IL-7R for CD4+ CD25+Foxp3+ T regulatory cells. J Immunol 2008; 181: 225.
52. Vang KB, Yang J, Mahmud SA, et al. IL-2,-7, and-15, but not thymic stromal lymphopoeitin, redundantly govern CD4+Foxp3+ regulatory T cell development. J Immunol 2008; 181: 3285.
53. Barrett EJ, Mensing C. The American Diabetes Association, the American Cancer Society, and the American Heart Association: A triumvirate of hope for the nation's health. Diabetes Care 2004; 27: 1789.